Novellia Raises $18M Series A
Novellia, based in New York, a company that operates a patient-powered data platform for pharmaceutical research, has raised $18 million in a Series A funding round. This latest investment brings the company's total funding to $28 million.
This round was led by Spark Capital, with participation from Khosla Ventures, Acrew Capital, Bling Capital, and TMV.
The capital will be used to scale Novellia's AI-powered technology, which enables patients to access and organize their complete health history across providers and share it with researchers to advance medical discoveries.
Novellia was founded to provide a patient-centered solution for medical research. Its platform uses AI and NLP models to unify patient health records, helping individuals track their health history and providing anonymized, harmonized datasets to pharmaceutical and diagnostic companies for research and development.
Funding Details
Company: Novellia
Raised: $18M
Round: Series A
Funding Date: June 2, 2026
Lead Investor: Spark Capital
Additional Investors: Khosla Ventures, Acrew Capital, Bling Capital, TMV
Company Website: http://www.novellia.com
Software Category: Health Data / AI